Condition
Unresectable Pancreatic Adenocarcinoma clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Unresectable Pancreatic Adenocarcinoma clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Unresectable Pancreatic Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TR-002 (Nadofaragene Firadenovec) given by IV for adults with advanced unresectable or metastatic solid tumors and refractory metastatic pancreatic adenocarcinoma | Phase 1 | Sacramento, California | Recruiting | Sep 23, 2025 |
| Adding panitumumab to chemotherapy for unresectable or metastatic KRAS wild-type pancreatic cancer | Phase 3 | Anchorage, Alaska and 273 other locations | Recruiting | May 31, 2025 |
| Observational study on cancer cachexia subtypes | — | Fort Smith, Arkansas and 224 other locations | Recruiting | Oct 10, 2023 |
| Testing a combination of two anti-cancer drugs for HER2-positive solid tumors | Phase 1 | Duarte, California and 17 other locations | Recruiting | May 13, 2022 |
All recruiting trials (4)
-
TR-002 (Nadofaragene Firadenovec) given by IV for adults with advanced unresectable or metastatic solid tumors and refractory metastatic pancreatic adenocarcinoma
This Phase 1 trial tests whether weekly intravenous TR-002 is safe and what dose is best for adults with advanced unresectable or metastatic solid tumors or refractory metastatic pancreatic cancer.
-
Adding panitumumab to chemotherapy for unresectable or metastatic KRAS wild-type pancreatic cancer
This trial will test whether giving the antibody panitumumab along with standard chemotherapy helps people with unresectable, locally advanced, or metastatic KRAS wild-type pancreatic cancer live longer.
-
Observational study on cancer cachexia subtypes
This study is trying to identify different types of weight and muscle loss in patients with advanced colorectal, lung, or pancreatic cancers to help improve future treatments.
-
Testing a combination of two anti-cancer drugs for HER2-positive solid tumors
This study is testing a combination of two cancer drugs to see if they can safely help people with advanced HER2-positive solid tumors.
Related topics
Quick answers
How many Unresectable Pancreatic Adenocarcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.